HHealth Read More FDA clears trial of dual-targeted CAR T-cell therapy for cancerSeptember 12, 2026 The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to…
HHealth Read More Scientists traced a hidden immune route that may worsen tau-linked brain damageSeptember 7, 2026 Researchers traced an immune pathway from brain-draining lymph nodes to tau-affected tissue, revealing how peripheral immune activity may…
HHealth Read More New study redefines high risk criteria for multiple myelomaJuly 20, 2026 Researchers have found that with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should…
HHealth Read More Why H2N2 flu is back on the pandemic preparedness radarApril 29, 2026 Decades after H2N2 vanished from humans, declining immunity and persistent animal reservoirs are renewing calls for stockpile-ready vaccines…
HHealth Read More Researchers uncover new mechanism linking metabolism, immunity, and skeletal healthApril 25, 2026 Obesity alters bone health not only through increased body weight but also by reshaping the bone marrow environment.…
HHealth Read More Scientists find unexpected immune pathways for mRNA cancer vaccinesApril 17, 2026 The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the…
HHealth Read More Clusterin inhibition offers new hope for treating cervical gastric-type adenocarcinomaApril 8, 2026 Gastric-type adenocarcinoma (GAS) is one of the most aggressive non-human papillomavirus (HPV)-associated cervical adenocarcinomas and remains especially difficult…
HHealth Read More New nanoparticle therapy overcomes T cell exhaustion in solid tumorsMarch 18, 2026 Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one…
HHealth Read More Chronic inflammation shapes cancer progression and immunotherapy responseFebruary 16, 2026 Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs,…
TTechnology Read More Silica nanomatrix enhances immunotherapy for solid tumorsDecember 31, 2025 Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of…
HHealth Read More Reprogramming camp for immune cells shows early promise for autoimmune diseasesDecember 4, 2025 Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune…
HHealth Read More Generative AI aids discovery of ISM3830’s novel scaffoldDecember 2, 2025 Casitas B-lineage lymphoma-b (CBLB) is an E3 ubiquitin–protein ligase that functions as an intracellular checkpoint and master negative…